Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
Clinical trial NCT06934057 · RECRUITING
Trial details
- NCT number
- NCT06934057
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-16
- Primary completion
- 2028-04-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.